Literature DB >> 10957986

Developing transgenic neuropeptide Y rats.

M Michalkiewicz1, T Michalkiewicz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10957986     DOI： 10.1385/1-59259-042-X:73

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN： 1064-3745


× No keyword cloud information.
  5 in total

1.  Germline transgenesis in rodents by pronuclear microinjection of Sleeping Beauty transposons.

Authors:  Zoltán Ivics; Lajos Mátés; Tien Yin Yau; Vladimír Landa; Vaclav Zidek; Sanum Bashir; Orsolya I Hoffmann; László Hiripi; Wiebke Garrels; Wilfried A Kues; Zsuzsanna Bösze; Aron Geurts; Michal Pravenec; Thomas Rülicke; Zsuzsanna Izsvák
Journal:  Nat Protoc       Date:  2014-03-13       Impact factor: 13.491

Review 2.  Transgenic modifications of the rat genome.

Authors:  Laurent Tesson; Jean Cozzi; Séverine Ménoret; Séverine Rémy; Claire Usal; Alexandre Fraichard; Ignacio Anegon
Journal:  Transgenic Res       Date:  2005-10       Impact factor: 2.788

3.  Advances in transgenic rat production.

Authors:  Wanda E Filipiak; Thomas L Saunders
Journal:  Transgenic Res       Date:  2006-09-29       Impact factor: 2.788

4.  Development and characterization of a highly selective neuropeptide Y Y5 receptor agonist radioligand: [125I][hPP1-17, Ala31, Aib32]NPY.

Authors:  Yvan Dumont; Mira Thakur; Annette Beck-Sickinger; Alain Fournier; Rémi Quirion
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

5.  Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.

Authors:  Edward W Lee; Mieczyslaw Michalkiewicz; Joanna Kitlinska; Ivana Kalezic; Hanna Switalska; Peter Yoo; Amarin Sangkharat; Hong Ji; Lijun Li; Teresa Michalkiewicz; Milos Ljubisavljevic; Hakan Johansson; Derrick S Grant; Zofia Zukowska
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.